OC 44.3 Exploring Red Blood Cells as a Novel Tolerogenic Approach for Factor VIII Inhibitors Employing Immuno-Dominant FVIII Derived Peptides Presented on MHC Class Ii

Autor: Miranda, M., Brandsma, E., Kaijen, P., Van Alphen, F., Van Bruggen, R., Fijnvandraat, K., Lacroix-Desmazes, S., Voorberg, J.
Zdroj: In Research and Practice in Thrombosis and Haemostasis October 2023 7 Supplement 2
Databáze: ScienceDirect
Externí odkaz: